PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 112 filers reported holding PULMONX CORP in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $16,913,638 | -39.9% | 2,667,766 | -12.2% | 0.00% | -100.0% |
Q1 2024 | $28,155,455 | -29.2% | 3,037,266 | -2.6% | 0.00% | 0.0% |
Q4 2023 | $39,742,553 | +31.1% | 3,117,063 | +6.2% | 0.00% | 0.0% |
Q3 2023 | $30,325,366 | -20.6% | 2,935,660 | +0.8% | 0.00% | 0.0% |
Q2 2023 | $38,173,252 | +26.2% | 2,911,766 | +7.6% | 0.00% | 0.0% |
Q1 2023 | $30,252,464 | +33.2% | 2,705,945 | +0.5% | 0.00% | 0.0% |
Q4 2022 | $22,707,386 | -44.8% | 2,693,640 | +9.1% | 0.00% | 0.0% |
Q3 2022 | $41,122,000 | +14.9% | 2,468,285 | +1.6% | 0.00% | 0.0% |
Q2 2022 | $35,776,000 | -47.8% | 2,430,317 | -11.9% | 0.00% | -50.0% |
Q1 2022 | $68,477,000 | -21.5% | 2,760,055 | +1.5% | 0.00% | 0.0% |
Q4 2021 | $87,177,000 | -11.5% | 2,718,331 | -0.7% | 0.00% | -33.3% |
Q3 2021 | $98,508,000 | -3.9% | 2,737,819 | +17.8% | 0.00% | 0.0% |
Q2 2021 | $102,520,000 | +144.5% | 2,323,639 | +153.4% | 0.00% | +200.0% |
Q1 2021 | $41,939,000 | -28.6% | 916,921 | +7.8% | 0.00% | -50.0% |
Q4 2020 | $58,708,000 | – | 850,608 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $789,274 | 14.32% |
KPCB XIII Associates, LLC | 994,971 | $13,044,070 | 5.83% |
PURA VIDA INVESTMENTS, LLC | 636,408 | $8,343,309 | 1.10% |
CFM WEALTH PARTNERS LLC | 264,039 | $3,461,551 | 0.84% |
BRAIDWELL LP | 999,362 | $13,101,636 | 0.43% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,064,285 | $13,952,776 | 0.30% |
Rock Springs Capital Management LP | 652,400 | $8,552,964 | 0.20% |
Olympiad Research LP | 13,210 | $173,183 | 0.17% |
Point72 Asset Management, L.P. | 3,326,065 | $43,604,712 | 0.13% |
PRIMECAP MANAGEMENT CO/CA/ | 5,519,721 | $72,363,542 | 0.06% |